
A podcast on statistical science and clinical trials. Explore the intricacies of Bayesian statistics and adaptive clinical trials. Uncover methods that push beyond conventional paradigms, ushering in data-driven insights that enhance trial outcomes while ensuring safety and efficacy. Join us as we dive into complex medical challenges and regulatory landscapes, offering innovative solutions tailore... more
| Publishes | Weekly | Episodes | 38 | Founded | 9 months ago |
|---|---|---|---|---|---|
| Number of Listeners | Categories | ScienceMedicineHealth & FitnessMathematics | |||

In this episode of "In the Interim…" guest host Cooper Berry moderates a detailed discussion on the evolution and practice of Bayesian methodology in clinical trials with fellow family members Dr. Don Berry, Dr. Scott Berry, Dr. Lindsay Berry, and Dr... more
In episode 37 of "In the Interim…", Dr. Jeff Saver, Director of the UCLA Comprehensive Stroke and Vascular Neurology Program, details his shift from behavioral neurology to clinical stroke research after early engagement with multicenter trials like ... more
In Episode 36 of "In the Interim…", Dr. Scott Berry and Dr. Don Berry analyze the Phase II trial of Lecanemab (BAN2401) in Alzheimer’s disease, focusing on the application of adaptive Bayesian methods following persistent failures in Alzheimer’s drug... more
On this episode of “In the Interim…”, which is co-sponsored by the Journal of Statistics and Data Science Education, Dr. Scott Berry talks with Dr. Jim Albert, Professor Emeritus at Bowling Green State University, whose extensive work encompasses Bay... more
People also subscribe to these shows.




How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.
Apple Podcasts | #12 | |
Apple Podcasts | #9 | |
Apple Podcasts | #39 | |
Apple Podcasts | #10 | |
Apple Podcasts | #22 | |
Apple Podcasts | #27 | |
Apple Podcasts | #3 | |
Apple Podcasts | #5 | |
Apple Podcasts | #6 | |
Apple Podcasts | #11 | |
Apple Podcasts | #15 | |
Apple Podcasts | #19 | |
Apple Podcasts | #20 | |
Apple Podcasts | #22 | |
Apple Podcasts | #23 | |
Apple Podcasts | #26 | |
Apple Podcasts | #33 | |
Apple Podcasts | #54 | |
Apple Podcasts | #122 | |
Apple Podcasts | #239 |
Recent interactions between the hosts and their guests.
Listeners, social reach, demographics and more for this podcast.
| Listeners per Episode | |
|---|---|
| Gender Skew | |
| Location | |
| Interests | |
| Professions | |
| Age Range | |
| Household Income | |
| Social Media Reach |
This podcast focuses on the realm of statistical science and clinical trials, with a particular emphasis on Bayesian statistics and adaptive trial methodologies. Each episode explores complex medical challenges, offering insights and discussions that push beyond traditional paradigms in clinical research. The content is driven by conversations with industry leaders who provide expert perspectives on innovative strategies for enhancing trial outcomes, ensuring patient safety, and navigating regulatory landscapes. Themes such as clinical trial design, statistical methodologies, and the integration of real-world data into research are prevalent, making it an invaluable resource for professionals in the pharmaceutical sector and beyond.
Rephonic provides a wide range of podcast stats for In the Interim.... We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to In the Interim... and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.
Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for In the Interim..., including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.
Rephonic provides comprehensive predictive audience data for In the Interim..., including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.
To see how many followers or subscribers In the Interim... has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.
These podcasts share a similar audience with In the Interim...:
1. The Peter Attia Drive
2. The Bulwark Podcast
3. The Daily
4. Up First from NPR
5. Radiolab
In the Interim... launched 9 months ago and published 38 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.
Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.
Rephonic pulls ratings and reviews for In the Interim... from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.
View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.
Rephonic provides full transcripts for episodes of In the Interim.... Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.
Recent guests on In the Interim... include:
1. Jeff Saver
2. Don Berry
3. Dr. Jim Albert
4. Andrew Thomson
5. Janet Wittes
6. Frank Harrell
7. Dr. Derek Angus
8. Michael Proschan
To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.